Search Results for: covid-19
Articles
September 29, 2020
Orgenesis Announces Agreement to Acquire Koligo Therapeutics
Orgenesis Inc. and Koligo Therapeutics, Inc. recently announced the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected completion….
September 29, 2020
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation
Mereo BioPharma Group plc recently announced that the US FDA has granted Rare Pediatric Disease designation to setrusumab for the...
September 22, 2020
TriNetX Acquired by Carlyle Group to Help Advance Health Research Optimization
TriNetX recently announced global investment firm The Carlyle Group has made a strategic growth investment and will acquire a majority...
September 22, 2020
ARCA biopharma Announces Submission of IND Application
ARCA biopharma, Inc. recently announced it has submitted an Investigational New Drug (IND) application with the US FDA under the Coronavirus...
September 15, 2020
Arctoris & Syntekabio Form Drug Discovery Research Partnership
Arctoris has recently signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts....
September 15, 2020
Fortress Biotech Announces Initiation of Phase 3 Studies
Fortress Biotech, Inc. recently announced that Caelum Biosciences, Inc., in collaboration with Alexion Pharmaceuticals, Inc., initiated the Cardiac Amyloid Reaching...
September 15, 2020
Catalent to be Added to S&P 500 Index
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell...
September 9, 2020
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
RedHill Biopharma Ltd. recently announced that opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral...
September 9, 2020
Liminal BioSciences Announces Resubmission of Biologics License Application
Liminal BioSciences Inc. recently announced the company, through its US subsidiary Prometic Biotherapeutics Inc., has filed a resubmission of the...
September 9, 2020
Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
Cynata Therapeutics Limited recently announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus mesenchymal...
